APOLLO HOSPITALS ENTER. L vs NGL FINE CHEM LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and NGL FINE CHEM LIMITED (NGLFINE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs NGLFINE on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
106.71
13.42
P/B ratio
6.01
0.11%
Dividend yield
0.05%
₹135.04
EPS
₹29.35

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
7.48%
18.00%
Return on capital
8.00%
15.00%
EBITDA margin
7.00%
7.94%
Net margin
5.01%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
22.13%
33.39%
Profit CAGR (3Y)
34.01%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹1,952 Cr
₹25,228 Cr
Revenue
₹359 Cr
₹2,003 Cr
Net profit
₹18 Cr
0.90
Debt / equity
0.34
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
NGL FINE CHEM LIMITED
  • + ["Company is expected to give good quarter"]
  • ["Stock is trading at 6.17 times its book value", "Company has a low return on equity of 12.1% over last 3 years."]
APOLLO HOSPITALS ENTER. L full analysis NGL FINE CHEM LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.